July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
New candidate treatment for clearing precipitate from the intraocular lens
Author Affiliations & Notes
  • Kazuichi Maruyama
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, OSAKA, Japan
  • Hirokazu Sakaguchi
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, OSAKA, Japan
  • Noriyasu Hashida
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, OSAKA, Japan
  • Shizuka Koh
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, OSAKA, Japan
  • Naoyuki Maeda
    Kosaki Eye Clinic, Japan
  • Kohji Nishida
    Ophthalmology, Osaka University Graduate School of Medicine, Suita, OSAKA, Japan
  • Footnotes
    Commercial Relationships   Kazuichi Maruyama, None; Hirokazu Sakaguchi, None; Noriyasu Hashida, None; Shizuka Koh, None; Naoyuki Maeda, None; Kohji Nishida, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3531. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kazuichi Maruyama, Hirokazu Sakaguchi, Noriyasu Hashida, Shizuka Koh, Naoyuki Maeda, Kohji Nishida; New candidate treatment for clearing precipitate from the intraocular lens. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3531.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the effect of macrolide antibiotic treatments on the visual acuity in patients who suffer from severe postsurgical intraocular lens precipitates.

Methods : The present study examined 13 eyes of 8 patients (7 females and 1 male, mean age: 68 ± 12.3 years) who underwent phacoemulsification + intraocular lens implantation (5 patients and 9 eyes) or pars plana vitrectomy + phacoemulsification + intraocular lens suture implantation (3 patients and 4 eyes) between April 2017 and February 2018 at Osaka University Hospital. Inclusion criteria included slit lamp examination findings that showed intraocular lens precipitate and cell infiltration in the aqueous humor in patients suffering from bronchiolitis who were treated with 400 mg/day of clarithromycin. Comparisons of the precipitation on the intraocular lens, visual acuity and area under the log contrast sensitivity function before and after treatment.

Results : There was a dramatic reduction in the precipitation on the intraocular lens at 1 month after treatment. Moreover, there was also significant improvement found for area under the log contrast sensitivity function (p=0.02). However, there was no improvement (no differences) in the visual acuity.

Conclusions : Oral administration of clarithromycin was able to improve visual function, especially contrast sensitivity, due to the subsequent reductions in the precipitate on the intraocular lens. Therefore, clarithromycin may be one of the potential candidates that can be used for treating intraocular lens precipitation after transplantation.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×